VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 61,464
Sort by:

Pituitary ACTH Hypersecretion (Cushing Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pituitary ACTH Hypersecretion (Cushing Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For eac...

February 2023 40 pages

Plague Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Plague Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Plague pipeline candidate, detai...

February 2023 40 pages

Poliomyelitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Poliomyelitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Poliomyelitis pipeline ca...

February 2023 100 pages

Polycystic Kidney Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Polycystic Kidney Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Polycystic Ki...

February 2023 150 pages

Polycystic Ovarian Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Polycystic Ovarian Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Polycystic...

February 2023 60 pages

Polycythemia Vera Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Polycythemia Vera Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Polycythemia Vera pip...

February 2023 80 pages

Pompe Disease Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pompe Disease Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pompe Disease pipeline ca...

February 2023 130 pages

Pontine Glioma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pontine Glioma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pontine Glioma pipeline...

February 2023 190 pages

Post Menopausal Osteoporosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Post Menopausal Osteoporosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Post Menop...

February 2023 200 pages

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Post-Polycythemia Vera Myelofibrosis (PPV-MF) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each...

February 2023 150 pages

Prader-Willi Syndrome (PWS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Prader-Willi Syndrome (PWS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Prader-Will...

February 2023 110 pages

Premature Labor (Tocolysis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Premature Labor (Tocolysis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Premature L...

February 2023 50 pages

Presbyopia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Presbyopia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Presbyopia pipeline candidat...

February 2023 90 pages

Pressure Ulcers Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pressure Ulcers Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pressure Ulcers pipelin...

February 2023 40 pages

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023....

February 2023 150 pages

Primary Immune Deficiency (PID) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Primary Immune Deficiency (PID) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Primary...

February 2023 130 pages

Primary Sclerosing Cholangitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Primary Sclerosing Cholangitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Primary...

February 2023 120 pages

Progressive Multifocal Leukoencephalopathy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Progressive Multifocal Leukoencephalopathy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of...

February 2023 50 pages

Progressive Supranuclear Palsy Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Progressive Supranuclear Palsy Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Progress...

February 2023 120 pages

Proliferative Diabetic Retinopathy (PDR) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Proliferative Diabetic Retinopathy (PDR) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of th...

February 2023 40 pages

Proliferative Vitreoretinopathy (PVR) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Proliferative Vitreoretinopathy (PVR) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the P...

February 2023 40 pages

Prosthetic Joint Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Prosthetic Joint Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Prosthetic...

February 2023 60 pages

Pruritus Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pruritus Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pruritus pipeline candidate, d...

February 2023 200 pages

Pseudomonas aeruginosa Pneumonia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pseudomonas aeruginosa Pneumonia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pseudo...

February 2023 40 pages

Pulmonary Embolism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pulmonary Embolism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pulmonary Embolism p...

February 2023 50 pages

Pyelonephritis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Pyelonephritis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Pyelonephritis pipeline...

February 2023 80 pages

Rabies Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rabies Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rabies pipeline candidate, detai...

February 2023 140 pages

Radiodermatitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Radiodermatitis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Radiodermatitis pipelin...

February 2023 80 pages

Rectal Cancer Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rectal Cancer Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rectal Cancer pipeline ca...

February 2023 190 pages

Recurrent Malignant Glioma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Recurrent Malignant Glioma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Recurrent Ma...

February 2023 50 pages

Reflux Esophagitis (Gastroesophageal Reflux Disease) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Reflux Esophagitis (Gastroesophageal Reflux Disease) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. Fo...

February 2023 130 pages

Resistant Pseudomonas aeruginosa Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Resistant Pseudomonas aeruginosa Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of...

February 2023 50 pages

Restenosis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Restenosis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Restenosis pipeline candidat...

February 2023 40 pages

Restless Legs Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Restless Legs Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Restless Legs Sy...

February 2023 40 pages

Retinal Vein Occlusion Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Retinal Vein Occlusion Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Retinal Vein Occ...

February 2023 140 pages

Retinoblastoma Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Retinoblastoma Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Retinoblastoma pipeline...

February 2023 60 pages

Retinopathy of Prematurity Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Retinopathy of Prematurity Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Retinopathy...

February 2023 90 pages

Rett Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rett Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rett Syndrome pipeline ca...

February 2023 200 pages

Rhinovirus Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rhinovirus Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rhinovirus Infect...

February 2023 120 pages

Rosacea Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rosacea Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rosacea pipeline candidate, det...

February 2023 110 pages

Rotavirus Infections Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rotavirus Infections Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rotavirus Infectio...

February 2023 90 pages

Rubella (German Measles) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Rubella (German Measles) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Rubella (Germa...

February 2023 50 pages

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of...

February 2023 40 pages

Sarcopenia Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sarcopenia Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Sarcopenia pipeline candidat...

February 2023 140 pages

Schistosomiasis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Schistosomiasis Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Schistosomiasis pipelin...

February 2023 40 pages

Secondary Hyperparathyroidism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Secondary Hyperparathyroidism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Secondary...

February 2023 50 pages

Secondary (Hypogonadotropic) Hypogonadism Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Secondary (Hypogonadotropic) Hypogonadism Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of t...

February 2023 40 pages

Sedation Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Sedation Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Sedation pipeline candidate, d...

February 2023 40 pages

Severe Acute Respiratory Syndrome (SARS) Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Severe Acute Respiratory Syndrome (SARS) Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of th...

February 2023 160 pages

Short Bowel Syndrome Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies

US$ 2,100.00

Short Bowel Syndrome Pipeline Report is a comprehensive report on the pre-clinical and clinical stage pipeline candidates under development as of H1  2023. For each of the Short Bowel Syndro...

February 2023 90 pages

Filters

Search

Categories

1,428
60
12,968
1,223
4,429
2
1
12,593
2,818
15,138
67
8,921
1
1,229
586

Publishers

61,464

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
61,427

Price

Date

Pages

Offers